Stroke after acute myocardial infarction: relation to infarct size

Area of Science:

• Cardiology
• Neurology
• Biochemistry

Background:

• Acute myocardial infarction (AMI) is a leading cause of mortality and morbidity.
• Stroke is a significant complication following AMI, impacting patient outcomes.
• Identifying predictors of post-MI stroke is crucial for risk stratification and management.

Purpose of the Study:

• To investigate the relationship between myocardial infarct size and the incidence of stroke after AMI.
• To determine if peak serum enzyme concentrations can serve as a surrogate marker for infarct size and stroke risk.
• To identify patient subgroups at negligible risk for stroke who may not require anticoagulant prophylaxis.

Main Methods:

• Prospective study of 783 consecutive patients with AMI.
• Measurement of peak serum creatine kinase (CK) and aspartate transaminase levels.
• Correlation analysis between peak enzyme concentrations, cumulated enzyme levels, and infarct size.
• Incidence of stroke was calculated based on peak CK levels.

Main Results:

• 13 (1.7%) patients experienced stroke post-MI.
• Stroke incidence was significantly higher (4.7%) in patients with peak CK > 1160 IU/l compared to those with lower levels (0.2%).
• Peak enzyme concentrations strongly correlated with infarct size, suggesting they reflect the extent of myocardial damage.

Conclusions:

• Stroke risk following AMI is directly proportional to the size of the myocardial infarct.
• Patients with smaller infarcts (lower peak CK levels) have a low risk of stroke and may not need anticoagulant therapy.
• Peak serum enzyme levels are reliable indicators of infarct size and can aid in clinical decision-making regarding stroke prophylaxis.